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Multiple effects of presumed glutathione depletors on rabbit proximal
tubules. The role of glutathione (OSH) in the protection of normal renal
function has heen investigated using rabbit proximal tubules. Com-
pounds known to deplete GSH in various biological systems by
alkylation (via USH S-transferases, phorone; 2-cyclohexen-l-one,
CMX; diethyl maleate, DEM) or by inhibiting GSH synthesis
(buthionine sulfoximine, BSO) were added to suspensions of proximal
tubules and incubated for 60 mi BSO (1 or 5 mM) did not decrease
GSH concentrations, 02 consumption, or cause lactate dehydrogenase
release (LDH). Concentrations of CHX (2 mM) and phorone (10 mM)
that decreased GSH concentrations also inhibited 02 consumption and
caused LDH release. DEM (10 mM) did not significantly decrease GSH
concentrations but did inhibit oxygen consumption and cause slight
LDH release, Time—course studies using CMX (3 msi) showed that
GSH levels and 02 consumption decreased as early as 15 mm while
LDH release did not occur until 60 mm. These results show that: I)
there may be a relationship between 02 consumption and GSH levels;
2) agents that have been used historically to reduce GSH concentrations
have other cytotoxic effects; and 3) rabbit renal proximal tubules appear
to be resistant to GSH depletion.
The tripeptide glutathione (GSH) is found in high concentra-
tions in mammalian cells and is thought to function directly or
indirectly in many cellular reactions [1]. The kidney contains
the biosynthetic and degradation enzymes involved in USH
metabolism and plays a major role in the interorgan metabolism
of GSH [1—3]. However, the role of OSH in normal kidney
function has not been extensively addressed. Suggestive evi-
dence has linked GSH to several physiological functions in
renal proximal tubules, including a role in intermediary metab-
olism, cellular respiration, gluconeogenesis and electrolyte
movements. For example, Leibach et al 1 4] reported that
diamide—induced decreases in intracellular GSH concentration
resulted in an inhibition of Na,K—ATPase activity, amino acid
uptake, gluconeogenesis and a decrease in sodium content in
renal cortical slices. Diamide, however, also has many other
effects, including non-specific oxidation of cellular macromol-
ecules, inhibition of cellular respiration, mitochondrial swelling
and altering cell membrane permeability [5]. Thus, the effects
seen by Leibach et al [4] may have not resulted specifically from
GSH depletion.
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Brezis et al [6] reported that "selective" GSH depletion can
be induced in the isolated, perfused rat kidney. "Selective"
USH depletion was accomplished by either inhibiting GSH
synthesis using the y-glutamylcysteine synthetase inhibitor
buthionine sulfoximine (BSO) or by alkylating GSH using
diethyl maleate (DEM) or 2-cyclohexen-1-one (CHX) [7]. DEM
and CHX interact with GSH by direct conjugation and/or via
the glutathione S-transferases to form a GSH adduct [8]. Their
results showed that GSH depletion was associated with an
increase in sodium excretion (up to sevenfold), an increase in
potassium excretion (up to 2.6—fold) and a decrease in concen-
trating ability. The increases in the fractional excretion of
sodium and potassium could result from altered transport
processes in the proximal tubules.
The purpose of this work was to study the role of GSH in
normal renal function at the cellular level. By using a well
defined suspension of proximal tubules with open lumens [9], it
was possible to examine the role(s) of OSH in renal function
without the complication of hydrodynamic effects and multiple
cell types found in whole kidney preparations. GSH concentra-
tions in the tubules were modified by either inhibiting GSH
synthesis using BSO or by alkylating GSH using DEM, CHX or
phorone. Phorone (2,6-dimethyl-2,5-heptadiene-4-one) is an-
other chemical that can interact with GSH via glutathione
S-transferases to form GSH adducts [10]. Following the addi-
tion of these compounds the quantity of respiration available to
support Na,K-ATPase—mediated ion transport, intracellular
OSH and lactate dehydrogenase (LDH) release were monitored
to determine tubular dysfunction.
Methods
Renal tubule suspension. Renal proximal tubules from female
New Zealand white rabbits (3 to 4 kg) were isolated according
to Soltoff and Mandel [9] with the following modification.
Dextran was omitted from all buffers following the in situ
perfusion. Tubules were resuspended (4 to S mg cellular protein/
mliter) in a buffer containing (in mM): 115 NaC1, 25 NaHCO3, 2
NaH2PO4, 1 CaCl2, 5 KC1, I MgSO4, 5 glucose, 4 sodium
lactate, 1 alanine, 5 sodium malate, and 2 sodium butyrate (pH
7.4).
Incubations of lubules. Tubules resuspended in the above
solution were incubated at 37°C and continuously gassed with
95% 02/5% CO2 in a gyrating shaker bath for 15 mm before the
addition of the OSH depletors. Various concentrations of the
OSH depletors were added (time 0) and the cells were allowed
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to incubate for an additional 60 mm unless otherwise stated. In
incubations in which BSO was added with a GSH alkylating
agent, the BSO was added at time —5 mm. Additional sodium
butyrate was added at time 30 mm for a final concentration of 2
mM. DEM, CHX and phorone were dissolved in dimethyl
sulfoxide and BSO was dissolved in distilled water. The final
volume of DMSO or distilled water added to the incubation was
less than 1 percent. At the appropriate time points, aliquots of
the tubule suspension were taken for 02 consumption, LDH
release and GSH concentrations.
GSH assay. Aliquots (1.0 mliter) of the tubule suspension
were layered on 0.4 mliter of a mixture of dibutyl phthalate and
dioctyl phthalate (2:1) and centrifuged for 2 mm in an Ep-
pendorf microcentrifuge. Following the removal of the buffer
and phthalate layer, the pellet was resuspended in 1.0 muter of
0.1 M sodium phosphate to 0.005 M EDTA buffer (pH 8.0).
Samples were then frozen and thawed three times, and an
aliquot taken for protein determination. Samples were then
centrifuged again for 2 mm in an Eppendorf centrifuge. An
aliquot (0.1 muter) of the resulting supernatant was added to 3.1
mliter of fresh phosphate—EDTA buffer and the amount of GSH
determined by the method of Hissin and Hilf [11].
LDH assay. An aliquot (1.0 mliter) of the tubule suspension
was layered on 0.4 mliter of dibutylldioctyl phthalate and
centrifuged for 2 mm in an Eppendorf microcentrifuge. 0.5
mliter of the supernatant was transferred to a new tube and was
frozen and thawed three times. In parallel, 0.5 mliter of the
tubule suspension was frozen and thawed three times. LDH
activity was determined by the method of Bergmeyer et al [12].
LDH activity was expressed as the percentage of activity found
in the media to the total activity.
Oxygen consumption. The rate of respiration of the tubule
suspension was monitored using a Clark—type oxygen electrode
and an oxymeter. The 1.6 mliter magnetically—stirred chamber
was thermostatically set at 37°C. Nystatin—stimulated respira-
tion was determined by adding approximately 1400 units of
nystatin to the chamber after obtaining a control respiratory
rate. To obtain the respiration rate not coupled to Na,K-
ATPase activity, ouabain (10—a M final concentration) was
added to the chamber.
Protein content. Protein content was determined by the
biuret method [13] following solubilization in 0.2 M NaOH/10%
deoxycholate. Bovine serum albumin was used as the protein
standard.
Chemicals. Mycostatin (nystatin) was purchased from Behr-
ing Diagnostics Corp. (San Diego, California, USA) and was
dissolved in dimethyl sulfoxide. Dextran T-40 and Ficoll were
obtained from Pharmacia Fine Chemicals (Piscataway, New
Jersey, USA). Collagenase (Type 1A), Protease (Type XIV),
GSH, DEM and ouabain were purchased from Sigma Chemical
Co. (St. Louis, Missouri, USA). Phorone (2,6-dimethyl-2,5-
heptadien-4-one), dimethyl suifoxide and 2-cyclohexen-1-one
were obtained from Aldrich Chemical Co. (Milwaukee, Wiscon-
sin, USA). All other chemicals were reagent grade.
Statistics. The data are presented as the mean SEM (N = 3
to 7). The data were either analyzed by one—way analysis of
variance with the means being compared by Fisher's protected
least significant difference procedure or the paired Students t
test [14]. A P value of less than 0.05 was considered significant.
Results
Buthionine sulfoximine
The addition of BSO (1 or 5 mM) to a suspension of rabbit
proximal tubules did not result in a reduction in GSH concen-
trations in 60 mm incubations (Fig. 1). While there was no effect
on GSH concentrations, 5 mM BSO caused a small decrease in
the amount of LDH released when compared to controls (7.9%
to 4.9%). In addition, 5 mrvi BSO caused a 25% increase in the
ouabain—sensitive nystatin—stimulated rate of oxygen consump-
tion (NYS—Q02) in the tubules. The NYS—Q02 is a measure of
the quantity of respiration available to support Na,K-ATPase
mediated ion transport and thus is a sensitive indicator of ion
transport and cellular health [15].
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Fig. 1. The concentration—dependent effects of buthionine sulfoximine
(BSO) on ouabain—sensitive nystatin—stimulated oxygen consumption(NYS—Q02), GSH concentrations and LDH release in rabbit proximal
tubules. Bars with different superscripts are significantly different from
one another (P 0.05).
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Fig. 2. The concentration—dependent effects of phorone on Fig. 3. The concentration—dependent effects of diethyl maleate (DEM)
ouabain—sensitive nysta tin—stimulated oxygen consumption on ouabain—sensitive nystatin—stimulated oxygen consumption(NYS—Q02), GSH concentrations and LDH release in rabbit proximal (NTS—Q02), GSH concentrations and LDH release in rabbit proximal
tubules. Bars with different superscripts are significantly different from tubules, Bars with different superscripts are significantly different from
one another (P  0.05). one another (P  0.05). *significantly different from 5 ma
concentration.
Phorone controls. These results suggest that phorone does not act
specifically to reduce GSH concentrations in this tissue and
The addition of 2 or 5 m phorone to the proximal tubules did concentrations that do deplete GSH are also cytotoxic.
not result in any change in GSH concentrations or in the
NYS—Q02 when compared to controls (Fig. 2) However,
.Diethyl inaleate
phorone at a concentration of 10 m caused a 55% decrease in The effects of DEM on proximal tubules were more complex
GSH concentrations and a 93% decrease in the NYS—Q02. than those seen with BSO and phorone (Fig. 3). GSH concen-
These changes were associated with a large decrease in cell trations were not altered by DEM over a concentration range of
viability as measured by 75% LDH release. The disproportional 2 to 10 mM. LDH release only increased over controls at a DEM
change in LDH release compared to OSH can be explained by concentration of 10 ms'i (8.1% to 14.3%). As with 10 mM
the method used to separate the tubules from the medium. Only phorone, the discrepancy seen between GSH concentrations
cells that are "functionally" intact will pass through the phthal- and LDH release can be explained by the phthalate separation
ate layer, thereby selecting less damaged cells. When GSH procedure. When GSH concentrations are expressed as percent
concentrations are expressed as percent of control and not of control and not normalized for mg protein, intracellular GSH
normalized for mg protein, intracellular GSH is 8 2% of is 90% of controls. At low concentrations of DEM (2 mM),
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NYS—Q02 was increased (21.2 vs. 17.3). However at a concen-
tration of 10 msi, DEM inhibited NYS—Q02 by 60%.
GSH depletion was then attempted by adding both a GSH
alkylating agent (DEM) and a GSH synthesis inhibitor (BSO).
The combination of 5 mst DEM and 5 mt,s BSO did not result in
a decrease in GSH concentrations. However, the combination
did result in a small decrease in NYS—Q02 and a small increase
in LDH leakage compared to 5 mrs DEM alone (Fig. 3). These
results suggest that DEM, like phorone, does not specifically
reduce GSH concentrations in this tissue, but is capable of
eliciting other cytotoxicities.
2-Cyclohexen-1 -one
GSH concentrations in the proximal tubules were not altered
by CHX until a concentration of 2 m was used (Fig. 4), which
caused a 25% reduction in GSH concentrations. Lower concen-
trations of CHX (0.5 mii and 1 ruM) inhibited NYS—Q02 17%
and 64%, respectively. Furthermore, a 1 m concentration of
CHX caused a small increased in LDH leakage, as compared to
controls.
GSH depletion was then attempted by adding both CHX and
BSO. The combination of 0.5 mrt CHX and 5 mtt BSO did not
change GSH concentrations, Q02 or LDH release when com-
pared to 0.5 mri CHX (Fig. 4).
To determine the sequence of events elicited by CHX, a
concentration of CHX was added (3 mM) to proximal tubules
that caused changes in GSH concentration, NYS—Q02 and
LDH release and samples were taken over time (15, 30 and 60
mm). Under these conditions, GSH concentrations as well as
the NYS—Q02 decreased within 15 mm and continued to
decrease throughout the 60 mm incubation (Fig. 5). In contrast,
LDH leakage, as measured by LDH activity, retention by the
tubules as percent of controls did not occur until the 60 mm time
point. These data show that reductions in GSH concentrations
and NYS—Q02 caused by CHX are early events in
CHX—induced cytotoxicity and that LDH release occurs at later
time points.
Discussion
The compounds used to reduce GSH concentrations in this
study have also been used in other tissues in vitro and in vivo.
For example, BSO (4 mM), DEM (1 mM) and phorone (0.5 mM)
decreased GSH concentrations in hepatocytes in 30 mm or less
[10, 16, 17]. However, unlike hepatocytes, the incubation of
CHX, DEM and phorone with rabbit renal proximal tubules
only resulted in reducing GSH concentrations when they also
caused plasma membrane damage, as measured by LDH re-
lease, and inhibited cellular respiration. CHX was the most
potent cytotoxicant followed by DEM and phorone. Attempts
to reduce GSH concentrations by adding both an alkylating
type of depletor and a synthesis inhibitor were unsuccessful in
decreasing GSH concentrations, compared to the alkylating
agent alone.
Experiments examining the time—dependent changes caused
by 3 ma'i CHX suggested that reductions in GSH concentrations
and inhibition of oxygen consumption were early changes
induced by this compound and preceded plasma membrane
damage as measured by LDH release. While the time—depen-
dent study could not determine whether a decrease in GSH
concentrations preceded a reduction in cellular respiration, the
biIa
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Fig. 4. The concentration—dependent effects of 2-cyclohexen-1-one
(CHX) on ouabain—sensitive nystatin-stimulated oxygen consumption
(NYS—Q02), GSH concentrations and LDH release in rabbit proximal
tubules. Bars with different superscripts are significantly different from
one another (P 0.05). *Not significantly different from 0.5 mM
concentration.
dose—response studies suggested that decreases in cellular
respiration preceded decreases in cellular GSH concentrations.
However, changes in GSH concentrations may have occurred
at low doses of CHX and were not identified. For example,
CHX could have decreased or shifted one of the intracellular
pools of GSH. These changes would not have been detected in
this study. The mechanism of CHX—induced inhibition of
cellular respiration remains to be determined.
The addition of BSO to the tubules did not result in a
reduction of GSH concentration in 60 mm incubations. The lack
of an effect by BSO may result from the incubation time used in
these studies, which are limited because the tubules begin to
deteriorate at longer time points. An interesting and unex-
plained finding is that 5 m BSO increased the NYS—Q02 and
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Fig. 5. The time—dependent effects of 3 ms 2-cyclohexen-1-one (CHX)
on ouabain—sensitive nystatin—stimulated oxygen consumption
(NYS—Q02), GSH concentrations and LDH content in rabbit proximal
tubules. LDH content was determined by subtracting the percent
release of LDH activity from 100 percent. *Significantly different from
control (P  0.05).
caused a small decrease in the amount of LDH released when
added to the tubules.
While the Brezis et al [6] study using the isolated perfused rat
kidney did not demonstrate a cause and effect relationship
between GSH reductions and altered renal function, there was
an association between OSH reductions and altered renal
function. Our results suggest that some of the results seen in the
rat kidney may be due to nonspecific effects of these com-
pounds. For example, CHX may cause plasma membrane
permeability changes which could result in an increase in
sodium and potassium excretion. Furthermore, by inhibiting
respiration and thus decreasing the amount of ATP available for
the Na,K-ATPase, an increased sodium excretion may result.
With a large increase in ion excretion it is not surprising that
concentrating ability decreases. However, the differences be-
tween this study and Brezis et al [6] may also be explained by
the differences in the species and experimental model.
While the lack of an effect by CHX, DEM and phorone is
puzzling, one possible explanation is that rabbit proximal
tubules have a low concentration of GSH S-transferases or the
isozymes of GSH S-transferases responsible for the metabolism
of these compounds.
In summary, the data suggest there may be a relationship
between GSH concentrations and QO2. Recent experiments
(manuscript in preparation) using 2-bromohydroquinone sup-
port this hypothesis. Agents that have been used historically to
reduce OSH concentrations can have other cytotoxic effects
and must be used cautiously. Finally, rabbit renal proximal
tubules appear to be more resistant to GSH depletion than
hepatocytes.
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